OTC Markets Group Welcomes Medicenna Therapeutics Corp. to OTCQX

GlobeNewswireOct 15 07:00 ET

Medicenna to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

GlobeNewswireOct 4 09:07 ET

Medicenna Announces Results of Annual Meeting of Shareholders

GlobeNewswireSep 26 17:00 ET

Medicenna Presents Preclinical Results From Its IL-2 Super-Antagonist and Anti-PD1-IL-2 BiSKIT Programs at The Promise of Interleukin-2 Therapy Conference

GlobeNewswireSep 9 07:32 ET

Medicenna to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswireSep 5 07:00 ET

Medicenna Announces Upcoming Presentations at The Promise of Interleukin-2 Therapy Conference

GlobeNewswireAug 27 07:00 ET